Cathie's Ark Logo
undefined Logo

ARKK Holdings of Intellia Therapeutics (NTLA) - Updated Daily

Gene TherapyGenomicsSynthetic BiologyGene Base EditingCRSPR Gene Editing
Morning Brew Icon
China's One Ocean Problem
Date
Direction
Shares
Fund Weight
Fund
March 26, 2024
BUY29.308k0.01%ARKK
March 25, 2024
BUY46.703k0.0162%ARKK
March 22, 2024
BUY81.826k0.028%ARKK
March 21, 2024
BUY133.244k0.047%ARKK
February 15, 2024
BUY21.877k0.0075%ARKK

Key Statistics

⚖️Weighting🧢Market Cap
2.56%$2.07b
🏋🏿‍♂️Weight Rank In ARKK🌏Country
14🇺🇸United States
🏋️‍♀️Weight Rank Across All Funds💳ARK Estimated Cost Average
14$62.04
🎫ARK Ownership Percent
7.83%

Other ETFs That Hold NTLA

Ticker
NameWeight
ARKGARK Genomic Revolution ETF3.95%
ARKKARK Innovation ETF3.77%
GNOMGlobal X Genomics & Biotechnology ETF3.28%
XBISPDR® S&P Biotech ETF1.12%
IBBiShares Biotechnology ETF0.31%
LABUS&P Biotech Bull 3X Shares ETF0.24%

Research Notes and Commentary for NTLA

No Research Notes Found for NTLA